• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建模血脂异常和血脂指标的危险因素:Ravansar 队列研究。

Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study.

机构信息

Professor of Biostatistics, Biostatistics Department, Social Development and Health Promotion Research Center, Kermanshah University of medical sciences, Kermanshah, Iran.

Master of Biostatistics, Student's research committee, Faculty of Health, Kermanshah University of medical sciences, Kermanshah, Iran.

出版信息

Lipids Health Dis. 2020 Jul 28;19(1):176. doi: 10.1186/s12944-020-01354-z.

DOI:10.1186/s12944-020-01354-z
PMID:32723339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7388539/
Abstract

BACKGROUND

Lipid disorder is one of the most important risk factors for chronic diseases. Identifying the factors affecting the development of lipid disorders helps reduce chronic diseases, especially Chronic Heart Disease (CHD). The aim of this study was to model the risk factors for dyslipidemia and blood lipid indices.

METHODS

This study was conducted based on the data collected in the initial phase of Ravansar cohort study (2014-16). At the beginning, all the 453 available variables were examined in 33 stages of sensitivity analysis by perceptron Artificial Neural Network (ANN) data mining model. In each stage, the variables that were more important in the diagnosis of dyslipidemia were identified. The relationship among the variables was investigated using stepwise regression. The data obtained were analyzed in SPSS software version 25, at 0.05 level of significance.

RESULTS

Forty percent of the subjects were diagnosed with lipid disorder. ANN identified 12 predictor variables for dyslipidemia related to nutrition and physical status. Alkaline phosphatase, Fat Free Mass (FFM) index, and Hemoglobin (HGB) had a significant relationship with all the seven blood lipid markers. The Waist Hip Ratio was the most effective variable that showed a stronger correlation with cholesterol and Low-Density Lipid (LDL). The FFM index had the greatest effect on triglyceride, High-Density Lipid (HDL), cholesterol/HDL, triglyceride/HDL, and LDL/HDL. The greatest coefficients of determination pertained to the triglyceride/HDL (0.203) and cholesterol/HDL (0.188) model with nine variables and the LDL/HDL (0.180) model with eight variables.

CONCLUSION

According to the results, alkaline phosphatase, FFM index, and HGB were three common predictor variables for all the blood lipid markers. Specialists should focus on controlling these factors in order to gain greater control over blood lipid markers.

摘要

背景

脂质紊乱是慢性疾病最重要的危险因素之一。确定影响脂质紊乱发展的因素有助于减少慢性疾病,尤其是慢性心脏病(CHD)。本研究旨在建立血脂紊乱和血脂指标的危险因素模型。

方法

本研究基于 Ravansar 队列研究(2014-16 年)初始阶段收集的数据进行。首先,通过感知器人工神经网络(ANN)数据挖掘模型对 33 个阶段的敏感性分析中可用的 453 个变量进行检查。在每个阶段,确定对血脂紊乱诊断更重要的变量。使用逐步回归研究变量之间的关系。使用 SPSS 软件版本 25 对获得的数据进行分析,显著性水平为 0.05。

结果

40%的研究对象被诊断为血脂异常。ANN 确定了与营养和身体状况有关的 12 个血脂紊乱预测变量。碱性磷酸酶、无脂肪质量(FFM)指数和血红蛋白(HGB)与所有七种血脂标志物均有显著关系。腰臀比是与胆固醇和低密度脂蛋白(LDL)相关性最强的最有效变量。FFM 指数对甘油三酯、高密度脂蛋白(HDL)、胆固醇/HDL、甘油三酯/HDL 和 LDL/HDL 的影响最大。决定系数最高的是包含九个变量的甘油三酯/HDL(0.203)和胆固醇/HDL(0.188)模型,以及包含八个变量的 LDL/HDL(0.180)模型。

结论

根据结果,碱性磷酸酶、FFM 指数和 HGB 是所有血脂标志物的三个共同预测变量。专家应重点控制这些因素,以便更好地控制血脂标志物。

相似文献

1
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study.建模血脂异常和血脂指标的危险因素:Ravansar 队列研究。
Lipids Health Dis. 2020 Jul 28;19(1):176. doi: 10.1186/s12944-020-01354-z.
2
High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.高水平的个体血脂谱和血脂比值作为2型糖尿病血糖控制不佳的预测指标。
Vasc Health Risk Manag. 2019 Jun 5;15:149-157. doi: 10.2147/VHRM.S209830. eCollection 2019.
3
Association between dyslipidemia and blood lipids concentration with smoking habits in the Kurdish population of Iran.伊朗库尔德人群中血脂异常与血脂浓度与吸烟习惯的关系。
BMC Public Health. 2020 May 13;20(1):673. doi: 10.1186/s12889-020-08809-z.
4
Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.血脂指标变化与冠心病发病:德黑兰血脂与血糖研究
Clin Biochem. 2014 Sep;47(13-14):1239-44. doi: 10.1016/j.clinbiochem.2014.03.004. Epub 2014 Mar 21.
5
Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.法国全科医疗中接受降脂治疗患者的混合性血脂异常:一项观察性研究。
Clin Ther. 2007 Aug;29(8):1671-81. doi: 10.1016/j.clinthera.2007.08.003.
6
Correlation of dyslipidemia with waist to height ratio, waist circumference, and body mass index in Iranian adults.伊朗成年人血脂异常与腰高比、腰围和体重指数的相关性。
Asia Pac J Clin Nutr. 2007;16(2):248-53.
7
Triglycerides to high-density lipoprotein cholesterol ratio is superior to triglycerides and other lipid ratios as an indicator of increased urinary albumin-to-creatinine ratio in the general population of China: a cross-sectional study.三酰甘油与高密度脂蛋白胆固醇比值优于三酰甘油和其他脂质比值,可作为中国一般人群尿白蛋白与肌酐比值升高的指标:一项横断面研究。
Lipids Health Dis. 2021 Feb 15;20(1):13. doi: 10.1186/s12944-021-01442-8.
8
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.美国接受他汀类药物治疗成年人中根据低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和载脂蛋白B划分的残余血脂异常:2009 - 2010年美国国家健康和营养检查调查
J Clin Lipidol. 2015 Jul-Aug;9(4):525-32. doi: 10.1016/j.jacl.2015.05.003. Epub 2015 May 16.
9
Dyslipidemia and its association with meibomian gland dysfunction.血脂异常及其与睑板腺功能障碍的关联。
Int Ophthalmol. 2016 Aug;36(4):469-76. doi: 10.1007/s10792-015-0149-4. Epub 2015 Oct 29.
10
Pediatric reference data of serum lipids and prevalence of dyslipidemia: Results from a population-based cohort in Germany.儿童血脂参考数据及血脂异常患病率:来自德国一项基于人群队列研究的结果
Clin Biochem. 2016 Jul;49(10-11):740-9. doi: 10.1016/j.clinbiochem.2016.02.010. Epub 2016 Mar 4.

引用本文的文献

1
Determinative sleep traits associated with dyslipidemia in obstructive sleep apnea patients.阻塞性睡眠呼吸暂停患者中与血脂异常相关的决定性睡眠特征。
BMC Pulm Med. 2025 Mar 8;25(1):105. doi: 10.1186/s12890-025-03480-9.
2
Application of Generative Artificial Intelligence in Dyslipidemia Care.生成式人工智能在血脂异常护理中的应用。
J Lipid Atheroscler. 2025 Jan;14(1):77-93. doi: 10.12997/jla.2025.14.1.77. Epub 2024 Dec 10.
3
Dietary intake of total, animal, and vegetable protein and cardiometabolic risk factors in patients with type 2 diabetes: using iso-energetic substitution models.

本文引用的文献

1
Differing Associations between Fatty Liver and Dyslipidemia According to the Degree of Hepatic Steatosis in Korea.韩国根据肝脂肪变性程度不同,脂肪肝与血脂异常之间的关联也不同。
J Lipid Atheroscler. 2019 Sep;8(2):258-266. doi: 10.12997/jla.2019.8.2.258. Epub 2019 Sep 21.
2
Association between dyslipidemia and blood lipids concentration with smoking habits in the Kurdish population of Iran.伊朗库尔德人群中血脂异常与血脂浓度与吸烟习惯的关系。
BMC Public Health. 2020 May 13;20(1):673. doi: 10.1186/s12889-020-08809-z.
3
The American Cancer Society Cancer Prevention Study-3 FFQ Has Reasonable Validity and Reproducibility for Food Groups and a Diet Quality Score.
2型糖尿病患者膳食中总蛋白、动物蛋白和植物蛋白的摄入量与心脏代谢危险因素:使用等能量替代模型
J Diabetes Metab Disord. 2025 Feb 1;24(1):60. doi: 10.1007/s40200-025-01571-2. eCollection 2025 Jun.
4
Diagnostic prediction model for screening of elevated low-density and non-high-density lipoproteins in young Thai adults between 20 and 40 years of age.20至40岁泰国年轻成年人中低密度脂蛋白升高和非高密度脂蛋白筛查的诊断预测模型
BMJ Health Care Inform. 2025 Jan 30;32(1):e101180. doi: 10.1136/bmjhci-2024-101180.
5
Socioeconomic inequalities and dyslipidaemia in adult population of the Ravansar Non-Communicable Disease Cohort Study: the role of sex and age.社会经济不平等与成年人群血脂异常:性别和年龄的作用——拉万萨尔非传染性疾病队列研究
BMJ Open. 2024 Nov 4;14(11):e085035. doi: 10.1136/bmjopen-2024-085035.
6
Diet-related inflammation is positively associated with atherogenic indices.饮食相关的炎症与动脉粥样硬化指数呈正相关。
Sci Rep. 2024 Jun 8;14(1):13190. doi: 10.1038/s41598-024-63153-1.
7
Dietary amino acid profile and risk of hypertension: findings from the Ravansar cohort study.饮食氨基酸谱与高血压风险:拉万萨尔队列研究的结果
BMC Nutr. 2024 May 2;10(1):68. doi: 10.1186/s40795-024-00878-2.
8
The association between dietary amino acid profile and the risk of type 2 diabetes: Ravansar non-communicable disease cohort study.饮食氨基酸谱与 2 型糖尿病风险的关联:Ravansar 非传染性疾病队列研究。
BMC Public Health. 2023 Nov 18;23(1):2284. doi: 10.1186/s12889-023-17210-5.
9
Major dietary patterns and dietary inflammatory index in relation to dyslipidemia using cross-sectional results from the RaNCD cohort study.主要饮食模式和饮食炎症指数与 RaNCD 队列研究的横断面结果相关联的血脂异常。
Sci Rep. 2023 Nov 4;13(1):19075. doi: 10.1038/s41598-023-46447-8.
10
Pro-inflammatory diet, cardio-metabolic risk factors and risk of type 2 diabetes: A cross-sectional analysis using data from RaNCD cohort study.促炎饮食、心血管代谢危险因素与 2 型糖尿病风险:基于 RaNCD 队列研究数据的横断面分析。
BMC Cardiovasc Disord. 2023 Jan 7;23(1):5. doi: 10.1186/s12872-022-03023-8.
美国癌症协会癌症预防研究-3 食物频率问卷在食物组和饮食质量评分方面具有合理的有效性和可重复性。
J Nutr. 2020 Jun 1;150(6):1566-1578. doi: 10.1093/jn/nxaa082.
4
Nutrients Intake in Individuals with Hypertension, Dyslipidemia, and Diabetes: An Italian Survey.高血压、血脂异常和糖尿病患者的营养摄入:一项义大利调查。
Nutrients. 2020 Mar 27;12(4):923. doi: 10.3390/nu12040923.
5
Cohort Profile: Ravansar Non-Communicable Disease cohort study: the first cohort study in a Kurdish population.队列简介:拉万萨尔非传染性疾病队列研究:库尔德人群中的第一项队列研究。
Int J Epidemiol. 2019 Jun 1;48(3):682-683f. doi: 10.1093/ije/dyy296.
6
The Prevalence of Dyslipidemia among Jordanians.约旦人血脂异常的患病率
J Lipids. 2018 Oct 28;2018:6298739. doi: 10.1155/2018/6298739. eCollection 2018.
7
Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study.中国农村人群血脂异常的流行率、知晓率、治疗率、控制率及其危险因素:河南农村队列研究。
Lipids Health Dis. 2018 May 22;17(1):119. doi: 10.1186/s12944-018-0768-7.
8
Dyslipidemia and its risk factors among urban middle-aged Iranians: A population-based study.伊朗城市中年人群中的血脂异常及其危险因素:一项基于人群的研究。
Diabetes Metab Syndr. 2016 Jul-Sep;10(3):149-56. doi: 10.1016/j.dsx.2016.01.009. Epub 2016 Mar 24.
9
The prevalence, awareness, treatment and control of dyslipidemia among adults in China.中国成年人血脂异常的患病率、知晓率、治疗率及控制率
Atherosclerosis. 2016 May;248:2-9. doi: 10.1016/j.atherosclerosis.2016.02.006. Epub 2016 Feb 27.
10
Selenium Level and Dyslipidemia in Rural Elderly Chinese.中国农村老年人群的硒水平与血脂异常
PLoS One. 2015 Sep 18;10(9):e0136706. doi: 10.1371/journal.pone.0136706. eCollection 2015.